Skip to main content

Institute for Clinical and Translational Research Archives

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

Read more

Health and Medicine Healthcare Solutions myVU myVU News Reporter Research Strategic Plan


Genomic research gains ad-“vantage” with new resources

Nov. 1, 2012—Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.

Read more

Reporter


Vanderbilt’s CTSA lands $46 million renewal

Jul. 12, 2012—Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million.

Read more

Health and Medicine myVU Reporter Research